Literature DB >> 9821474

Release of granule proteins from human eosinophils stimulated with mast-cell mediators.

S Takafuji1, K Tadokoro, K Ito, T Nakagawa.   

Abstract

BACKGROUND: It has been suggested that mast cells and eosinophils are major effector cells in the pathogenesis of allergic diseases. However, the interaction of these cells has not been thoroughly elucidated. We examined eosinophil cationic protein (ECP) release and cytosolic free calcium concentration ([Ca2+]i) in human eosinophils induced by the major mast-cell mediators including cytokines.
METHODS: Eosinophils from healthy donors were stimulated with the major mast-cell mediators for 20 min after preincubation with cytochalasin B for 10 min. ECP in supernatants was measured by radioimmunoassay. Moreover, to examine changes of [Ca2+]i in eosinophils, Fura-2-loaded eosinophils were monitored for fluorescence changes after stimulus addition.
RESULTS: Of the tested mediators (prostaglandin [PG]D2, leukotriene (LT)B4, platelet-activating factor (PAF), histamine, LTC4, and eosinophil chemotactic factor of anaphylaxis [ECF-A]), LTB4 and PAF induced ECP release from eosinophils. Any cytokines produced by human mast cells, i.e., interleukin (IL)-4, IL-5, IL-8, tumor necrosis factor (TNF), or granulocyte-macrophage colony-stimulating factor (GM-CSF), did not induce ECP release in our system. ECP release triggered with LTB4 and PAF occurred at concentrations of 10(-8)-10(-6) M concentration-dependently. LTB4 and PAF also elicited a rise in [Ca2+]i in eosinophils. Neither PGD2, histamine, nor LTC4 induced ECP release, although they increased cytosolic calcium in eosinophils.
CONCLUSIONS: Of mast-cell mediators, LTB4 and PAF induced eosinophil degranulation. The contribution of LTB4 and PAF from mast cells to eosinophil degranulation may be important in the pathogenesis of allergic inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9821474     DOI: 10.1111/j.1398-9995.1998.tb03795.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  8 in total

1.  Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptor.

Authors:  Kimberly D Dyer; Caroline M Percopo; Zhihui Xie; Zhao Yang; John Dongil Kim; Francis Davoine; Paige Lacy; Kirk M Druey; Redwan Moqbel; Helene F Rosenberg
Journal:  J Immunol       Date:  2010-04-26       Impact factor: 5.422

Review 2.  Mast cells and eosinophils: the two key effector cells in allergic inflammation.

Authors:  Yael Minai-Fleminger; Francesca Levi-Schaffer
Journal:  Inflamm Res       Date:  2009-05-08       Impact factor: 4.575

Review 3.  Analysing the eosinophil cationic protein--a clue to the function of the eosinophil granulocyte.

Authors:  Jonas Bystrom; Kawa Amin; David Bishop-Bailey
Journal:  Respir Res       Date:  2011-01-14

4.  Polymorphisms in the RNASE3 gene are associated with susceptibility to cerebral malaria in Ghanaian children.

Authors:  Bright Adu; Daniel Dodoo; Selorme Adukpo; Ben A Gyan; Paula L Hedley; Bamenla Goka; George O Adjei; Severin O Larsen; Michael Christiansen; Michael Theisen
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

5.  Genetic variants of RNASE3 (ECP) and susceptibility to severe malaria in Senegalese population.

Authors:  Gora Diop; Céline Derbois; Cheikh Loucoubar; Babacar Mbengue; Bineta Niakhana Ndao; Fatou Thiam; Alassane Thiam; Rokhaya Ndiaye; Yakhya Dieye; Robert Olaso; Jean-Francois Deleuze; Alioune Dieye
Journal:  Malar J       Date:  2018-02-05       Impact factor: 2.979

6.  Open-label, add-on trial of cetirizine for neuromyelitis optica.

Authors:  Ilana Katz Sand; Michelle T Fabian; Russell Telford; Thomas A Kraus; Mirna Chehade; Madhan Masilamani; Thomas Moran; Colleen Farrell; Shelly Ebel; Lawrence J Cook; John Rose; Fred D Lublin
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-02-02

7.  LTB4 increases nasal neutrophil activity and conditions neutrophils to exert antiviral effects.

Authors:  Henrik Widegren; Morgan Andersson; Pierre Borgeat; Louis Flamand; Sebastian Johnston; Lennart Greiff
Journal:  Respir Med       Date:  2011-01-19       Impact factor: 3.415

8.  Eosinophils in fungus-associated allergic pulmonary disease.

Authors:  Sumit Ghosh; Scott A Hoselton; Glenn P Dorsam; Jane M Schuh
Journal:  Front Pharmacol       Date:  2013-02-01       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.